Stryker Corp
Open
SectorHealthcare
308.67 -0.98
Overview
Share price change
24h
Min
306.54
Max
311.86
Income | -104M 745M |
|---|---|
Sales | -1.2B 6B |
P/E Sector Avg | 34.859 49.052 |
EPS | 1.93 |
Dividend yield | 1.13 |
Profit margin | 12.375 |
Employees | 56,000 |
EBITDA | -478M 1.2B |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +24.16% upside |
Dividend yield Sector Avg | 1.13% 2.36% |
|---|---|
Next Earnings | 30 lip 2026 |
Next Dividend date | 31 lip 2026 |
Next Ex Dividend date | 30 cze 2026 |
Market Cap | -10B 116B |
|---|---|
Previous open | 309.65 |
Previous close | 308.67 |
News Sentiment
By Acuity
53%
47%
272 / 342 Ranking in Healthcare
Stryker Corp Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
About Stryker Corp
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.